[1] |
LIANG Jie.
172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
|
[2] |
WANG Chunting, CHEN Yafei.
Considerations for Revision of Safety Information in the Post-Marketing Instructions of Chemical Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 776-779.
|
[3] |
TAO Xingru, DUAN Yanyan, LIU Xiaoling, LIU Yuemei, ZHANG Shengnan.
One Case of Black Hairy Tongue Caused by Doxycycline
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 696-698.
|
[4] |
LUO Wen, WU Jing, HE Dake, YANG Rui.
One Case of Dermatitis Medicamentosa in a Paediatric Epilepsy Patient Caused by Lacosamide Oral Solution
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 452-455.
|
[5] |
JIA Zhichao, HU Siyuan, LI Ruiben, XU Yaqian.
Safety of Children’s Traditional Chinese Medicine Decoction Pieces in Clinical Application and Children’s Drug Development
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 324-328.
|
[6] |
ZOU Yuanlei, XIA Qingrong, LIANG Jun, HE Kongliang, MO Daming, WU Wenning.
Words of Warning and Preventive Measures in Labels of Antidepressants
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 329-333.
|
[7] |
SHAO Bo, ZHONG Lumiao, CHENG Yuzhu, DENG Hua, ZHU Lan.
Risks to Safety of Yinhuang Oral Preparation
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 84-87.
|
[8] |
MENG kangkang, XIA Yukun.
Risks to safety of Ondansetron preparations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1034-1038.
|
[9] |
LIU Ting, CAO Zhongqiang, HE Wenjia, YUAN Xiuli, CHEN Zebin, LI Xuejuan.
One case of acute severe pancreatitis caused by pegaspargase and its etiology
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1075-1077.
|
[10] |
CHAO Ying, ZHANG Xuemei, ZHANG Chengjian, WANG Bei.
One case of ureterolith combined with gallstone caused by Ceftriaxone sodium for injection in children
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 943-945.
|
[11] |
SHAO Bo, GUO Xiaoxin.
Review of pharmacovigilance of traditional Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 741-745.
|
[12] |
CHENG Yijing, LI Tao, LIU Junting, HUANG Guimin, ZHONG Xuli, LIN Aihua, PAN Shoudong, LI Long, BAI Dongsheng, ZHAN Xiaojun, LIU Zhenjiang, REN Wei, NIE Xiaolu, TAI Jun.
Safety evaluation of haemocoagulase agkistrodon for injection in children based on real world data
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 787-790.
|
[13] |
LIU Yan, AN Jing, JIAO Yongzhuo, LIANG Xuefeng, ZHANG Xiaoshu.
Simple febrile seizures within 30 days of vaccination with the measles, mumps and rubella combined attenuated live vaccine in U-12 children in the real world
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 805-810.
|
[14] |
ZHAO Jie, GAO Ming'e, CHANG Hong, FAN Huixia.
Two cases of allergic reactions in children caused by compound polyethylene glycol electrolyte powder
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 816-818.
|
[15] |
YU Jing, PALATI Reheman, ZHAO Ting, FENG Jirong, SUN Yan, HE Lei.
Correlation of the efficacy, safety and plasma concentration of lacosamide in the treatment of children with epilepsy under 4 years of age
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 559-562.
|